Mpox in Africa prompts $500 million funding from Gavi for vaccines
Adds DRC government comments in paragraphs 15-16
By Jennifer Rigby
LONDON, Aug 15 (Reuters) -The global vaccine group Gavi has up to $500 million to spend on getting shots to countries affected by an escalating mpox outbreak in Africa, its chief executive Sania Nishtar told Reuters.
Gavi helps countries with fewer resources buy and deploy vaccines, usually against childhood diseases like measles, but it expanded into broader efforts during the COVID-19 pandemic.
The money is available in the organization’s "First Response" fund, which was set up after global health agencies like Gavi were left behind by high-income countries in procuring vaccines during the early days of COVID.
It can be used to respond to health emergencies, which were declared by the World Health Organization and the Africa Centres for Disease Control and Prevention (CDC) this week.
The funds are largely left over from money donated by governments and global health funders for the COVID response.
“The money for the vaccines is ready to be tapped into,” said Nishtar, but there were hurdles to clear, including official requests for vaccines from affected countries, as well as approvals of the vaccines from the World Health Organization, which declared mpox a global health emergency on Wednesday.
Gavi and UNICEF, which work together to buy vaccines, cannot do so without WHO approving them. On Wednesday, the global health agency said it was hoping to finalise its evaluation of the vaccines by September.
Nishtar said Gavi was also in early talks with the manufacturers of the two mpox vaccines that are widely used, made by Bavarian Nordic BAVA.CO and KM Biologics. Official orders can only proceed after approval, she said.
Bavarian Nordic has said it can make 10 million doses by the end of 2025.
"We have already significant capacity in place and can easily handle delivery of all doses needed for the outbreak," a Bavarian Nordic spokesperson said by email.
"But we need someone to buy the doses. None of the organizations have shown interest so far," he added, without providing details.
KM Biologics said in an email it would cooperate with WHO as much as possible.
In the meantime, Gavi is coordinating with countries like the United States, which has had 50,000 doses available for donation for months. Bavarian Nordic has also donated 15,000 doses.
However, the Democratic Republic of Congo, which has been severely affected by the outbreak, has yet to make an official request for the shots, which Nishtar said was a delaying factor, along with arranging legal processes and deployment plans for vaccination.
In a press conference on Thursday, Congo's health minister Samuel Roger Kamba Mulamba said the country needs 3 million vaccine doses.
"That's why it was important to wake up the international community," he said.
Reporting by Jennifer Rigby in London and Ange Adihe Kasongo in Kinshasa; Editing by Bernadette Baum and Jonathan Oatis
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
